FXN and Friedreich ataxia: It has recently been demonstrated that targeting Sonic Hedgehog (SHH) with the Smoothened antagonist (SAG) rescued mitochondrial dysfunction and reverted the neurotoxicity induced by the lack of FXN in human astrocytes in vitro, showing the potential of pharmacologically targeting astrocytes cells to attenuate neurodegeneration in FRDA [46].